Califf on ac­cel­er­at­ed ap­provals: Com­pa­nies need to do more work be­fore FDA says OK

As he awaits a tight Sen­ate vote, Rob Califf, Pres­i­dent Joe Biden’s nom­i­nee to be the next FDA com­mis­sion­er, is sig­nal­ing where the agency may move on ac­cel­er­at­ed ap­provals if he takes over at FDA.

Build­ing off com­ments from his Sen­ate con­fir­ma­tion hear­ing, in which Califf said that he’s “a fan of ac­cel­er­at­ed ap­proval” but the US needs a bet­ter sys­tem to eval­u­ate these drugs once they’re on the mar­ket, the nom­i­nee raised ques­tions about how well the cur­rent struc­ture serves pa­tients.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER